Jamie Justice - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Jamie Justice's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Jamie Justice
Verified
Group News Director, Sinclair Inc.
Columbus
Beats
Class ImmigrationLabor Race and Urban Development.
Content
By Chiara Herzog, Kejun Ying, Raghav Sehgal, Waylon J. Hastings, Alexander Tyshkovskiy, Sara Hägg, John Earls Verified, Christian Behrens, Jessica Lasky-Su, John S. Tsang, Riccardo E Marioni, M. Austin Argentieri, Lynne Cox, Gordan Lauc, David Furman, Jason D. Buenrostro, Björn Schumacher, Jamie Justice, David Sinclair, Andrea B. Maier, Michael Snyder, Tony Wyss-Coray, Steve Horvath, Luigi Ferrucci, Jesse R. Poganik| Nature Verified On 1–2 November 2024, the annual Biomarkers of Aging conference welcomed academic and industry scientists, and partners from governmental and nongovernmental organizations, to Harvard Medical School in Boston, USA, to discuss new insights into measuring and monitoring human aging, with the aim of clinical translation. In this Meeting Report, we summarize the conference and offer potential future directions for the Biomarkers of Aging Consortium and the longevity science community at large.
By Jesse R. Poganik, Daniel Belsky, Joe LaCroix, Alan Cohen, Steven R. Cummings, Luigi Ferrucci, David Furman, Albert T. Higgins-Chen, Steve Horvath, Jamie Justice, Douglas P Kiel, George A. Kuchel, Jessica Lasky-Su, Nathan K. LeBrasseur, Andrea B. Maier, Birgit Schilling, Vittorio Sebastiano, P. Eline Slagboom, Michael Snyder, Eric Verdin, Alex Zhavoronkov| Nature Verified AbstractBiomarkers of aging (BOA) are quantitative parameters that predict biological age and ideally its changes in response to interventions. In recent years, many promising molecular and omic BOA have emerged with an enormous potential for translational geroscience and improving healthspan. However, clinical translation remains limited, in part due to the gap between preclinical research and the application of BOA in clinical research and other translational settings.
By Chiara Herzog, Kejun Ying, Raghav Sehgal, Waylon J. Hastings, Alexander Tyshkovskiy, Sara Hägg, John Earls Verified, Christian Behrens, Jessica Lasky-Su, John S. Tsang, Riccardo E Marioni, M. Austin Argentieri, Lynne Cox, Gordan Lauc, David Furman, Jason D. Buenrostro, Björn Schumacher, Jamie Justice, David Sinclair, Andrea B. Maier, Michael Snyder, Tony Wyss-Coray, Steve Horvath, Luigi Ferrucci, Jesse R. Poganik| Nature Verified On 1–2 November 2024, the annual Biomarkers of Aging conference welcomed academic and industry scientists, and partners from governmental and nongovernmental organizations, to Harvard Medical School in Boston, USA, to discuss new insights into measuring and monitoring human aging, with the aim of clinical translation. In this Meeting Report, we summarize the conference and offer potential future directions for the Biomarkers of Aging Consortium and the longevity science community at large.
Company Info
Sinclair Inc.
Cockeysville, Maryland, United States
+1 410-568-1500